Development of anaphylactic shock in haemophilia B patients with inhibitors.

Article

Development of anaphylactic shock in haemophilia B patients with inhibitors.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Mar 1998

Warrier I, Lusher J M

Abstract excerpt

The development of inhibitor antibody is a serious complication of haemophilia in young children. The incidence of factor IX (FIX) inhibitors in haemophilia B patients is five- to 10-times less common (1.5-3%) than the incidence of FVIII inhibitors in haemophilia A (15-30%). Inhibitors are common...

Topics

Anaphylaxis
Antibodies
Factor IX
Genotype
Hemophilia B
Humans
Immune Tolerance
Nephrotic Syndrome
Recombinant Proteins

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.